A group of East London-based volunteers who include doctors, engineers and entrepreneurs, has developed a portable and easy-to-use oxygen device that can be used by less skilled healthcare workers at clinic level in the fight against COVID-19.
“Pres Cyril Ramaphosa will have to forgive us for not being impressed by the government’s vaccination strategy, which reads more like an exercise in damage control,” reported Business Day in it’s Editorial Comment (13 January 2021).
Medical Brief (13 January 2021) reports that - according to a global survey - many victims of COVID are still unable to work at full capacity six months after infection. Among the symptoms of ‘Long Covid’ are fatigue, post-exertional malaise, ‘brain fog’, neurological sensations, headaches, memory problems, insomnia, muscle aches, palpitations, shortness of breath, and dizziness, speech and language problems. Memory and cognitive dysfunction were experienced by more than 85% of the respondents.
The global pharmaceutical company AstraZeneca does not hold the rights to sell its C-19 vaccine (the cheapest on the market) in SA, reported News24 (13 January 2021). These rights belong to the Serum Institute of India (SII).